International Stem Cell Corporation
ISCO
$0.115
$0.02527.78%
| 09/30/2024 | 06/30/2024 | ||||
|---|---|---|---|---|---|
| Revenue | -6.52% | 9.49% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -6.52% | 9.49% | |||
| Cost of Revenue | 6.68% | 2.93% | |||
| Gross Profit | -15.02% | 14.17% | |||
| SG&A Expenses | -11.78% | 1.05% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 3.99% | -5.42% | |||
| Operating Income | -160.40% | 183.71% | |||
| Income Before Tax | -205.04% | 155.61% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -205.04% | 155.61% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -205.04% | 155.61% | |||
| EBIT | -160.40% | 183.71% | |||
| EBITDA | -118.59% | 254.26% | |||
| EPS Basic | -302.60% | 128.84% | |||
| Normalized Basic EPS | -205.38% | 155.69% | |||
| EPS Diluted | -302.60% | 125.67% | |||
| Normalized Diluted EPS | -205.38% | 155.69% | |||
| Average Basic Shares Outstanding | 0.00% | 0.00% | |||
| Average Diluted Shares Outstanding | 0.00% | 0.00% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||
